Blood Borne Diseases Screening Panel
MagIA diagnostics infectious diseases panel detects Hepatitis B, Hepatitis C and HIV all in once. The rapid and accurate knowledge of the presence or absence of the related pathogens help make timely decisions about treatment, vaccination, and infection control. MagIA diagnostics will decline this panel in 3 kits for modular diagnostic approach: from a single capillary blood sample, MagIA infectious diseases panel detects the pathogens that most commonly present a co-infection: Hepatitis B, Hepatitis C and HIV.
Our MagIA HCV-HIV2 assay is dedicated to multiparametric rapid testing of hepatitis C and HIV. By detecting HIV-1/2 antibodies, p24 antigen and HCV antibodies, this assay allows for rapid early detection of HIV infection and/or present or past HCV infection.
Our MagIA HBV3 assay is dedicated to multiparametric rapid testing of hepatitis B. By identifying the presence of the Hepatitis B Surface Antigen (HbsAg), along with related antibodies anti-HBs and anti-HBc, this kit allows for a rapid decision between Hepatitis B infection and vaccination.
Syphilis
Syphilis detection will be implemented into blood borne diseases screening panel to integrate the recrudescence of this infectious disease.
Tropical fever cartridge
A tropical fever kit will allow the parallel detection of Dengue fever, Chikungunya and Zika.
MagIA HBV-HCV-HIV first assay is dedicated to multiparametric rapid testing of hepatitis B, C and HIV all in once. By detecting the Hepatitis B Surface Antigen (HbsAg), along with HCV and HIV-1/2 antibodies, this assay allows for simultaneous detection of 3 main blood borne diseases.
Easy preparation: Collect 50 µl of sample, dilute in the provided bottle and inject into 1 or 2 cartridges
Time to results: 20 minutes after cartridge(s) insertion in MagIA Analyzer
Sample: Capillary blood, veinous blood, serum, plasma
Shelf life: 12 months
Storage: 10 – 37°C